8EDM
Cryo-EM structure of the full-length human NF1 dimer
8EDM の概要
| エントリーDOI | 10.2210/pdb8edm/pdb |
| EMDBエントリー | 28036 |
| 分子名称 | Isoform I of Neurofibromin (1 entity in total) |
| 機能のキーワード | gtpase activating protein, ras signaling, cancer, signaling protein |
| 由来する生物種 | Homo sapiens (human) |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 634821.62 |
| 構造登録者 | Darling, J.E.,Merk, A.,Grisshammer, R.,Ognjenovic, J. (登録日: 2022-09-05, 公開日: 2023-09-27, 最終更新日: 2025-05-21) |
| 主引用文献 | Young, L.C.,Goldstein de Salazar, R.,Han, S.W.,Huang, Z.Y.S.,Merk, A.,Drew, M.,Darling, J.,Wall, V.,Grisshammer, R.,Cheng, A.,Allison, M.R.,Sale, M.J.,Nissley, D.V.,Esposito, D.,Ognjenovic, J.,McCormick, F. Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization. Proc.Natl.Acad.Sci.USA, 120:e2208960120-e2208960120, 2023 Cited by PubMed Abstract: The majority of pathogenic mutations in the neurofibromatosis type I () gene reduce total neurofibromin protein expression through premature truncation or microdeletion, but it is less well understood how loss-of-function missense variants drive NF1 disease. We have found that patient variants in codons 844 to 848, which correlate with a severe phenotype, cause protein instability and exert an additional dominant-negative action whereby wild-type neurofibromin also becomes destabilized through protein dimerization. We have used our neurofibromin cryogenic electron microscopy structure to predict and validate other patient variants that act through a similar mechanism. This provides a foundation for understanding genotype-phenotype correlations and has important implications for patient counseling, disease management, and therapeutics. PubMed: 36689660DOI: 10.1073/pnas.2208960120 主引用文献が同じPDBエントリー |
| 実験手法 | ELECTRON MICROSCOPY (3.6 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






